Wordt geladen...
In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
Current therapies against hepatitis B virus (HBV) do not reliably cure chronic infection, necessitating new therapeutic approaches. The T cell response can clear HBV during acute infection, and the adoptive transfer of antiviral T cells during bone marrow transplantation can cure patients of chronic...
Bewaard in:
| Gepubliceerd in: | Mol Ther Methods Clin Dev |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Gene & Cell Therapy
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626922/ https://ncbi.nlm.nih.gov/pubmed/29018834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2017.08.006 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|